Study Augmenting TAK-659 Action in Relapsed/Refractory AML by Addition Ofthe Proteasome Inhibitor Ixazomib
Clinical trial NCT04079738 · TERMINATED
Trial details
- NCT number
- NCT04079738
- Sponsor
- H Scott Boswell
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-20
- Primary completion
- 2021-09-22
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.